This inventor holds 1 USPTO granted patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Yatinda M Joshi: Innovator in Pharmaceutical Formulations
Introduction
Yatinda M Joshi is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His innovative work has led to the development of a unique formulation that enhances the effectiveness of a well-known drug.
Latest Patents
Yatinda M Joshi holds a patent for a formulation titled "Captopril formulation providing increased duration of activity." This patent describes a formulation that comprises captopril within an enteric or delayed-release coated pH stable core. It also includes additional captopril that is available for immediate release following administration. This innovative approach aims to improve the duration of activity of captopril, a medication commonly used to treat high blood pressure and heart failure.
Career Highlights
Yatinda M Joshi is associated with E. R. Squibb Sons, Inc., where he has contributed to various pharmaceutical advancements. His work in the company has been instrumental in developing formulations that enhance drug efficacy and patient outcomes. His dedication to research and innovation has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Yatinda has collaborated with esteemed colleagues, including Robert Abramowitz and Nemichand B Jain. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical formulations.
Conclusion
Yatinda M Joshi's contributions to pharmaceutical formulations exemplify the impact of innovation in medicine. His patent for an improved captopril formulation showcases his commitment to enhancing drug effectiveness. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
